Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Inhibition of HIV Replication by Cyclic and Hairpin PNAs Targeting the HIV-1 TAR RNA Loop.

Upert G, Di Giorgio A, Upadhyay A, Manvar D, Pandey N, Pandey VN, Patino N.

J Nucleic Acids. 2012;2012:591025. doi: 10.1155/2012/591025. Epub 2012 Sep 17.

2.

Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.

Kaushik N, Basu A, Pandey VN.

Antiviral Res. 2002 Oct;56(1):13-27.

PMID:
12323396
3.

Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.

Mayhood T, Kaushik N, Pandey PK, Kashanchi F, Deng L, Pandey VN.

Biochemistry. 2000 Sep 26;39(38):11532-9.

PMID:
10995220
4.
5.

Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.

Tripathi S, Chaubey B, Ganguly S, Harris D, Casale RA, Pandey VN.

Nucleic Acids Res. 2005 Aug 2;33(13):4345-56. Print 2005.

6.

An efficient biodelivery system for antisense polyamide nucleic acid (PNA).

Mehiri M, Upert G, Tripathi S, Di Giorgio A, Condom R, Pandey VN, Patino N.

Oligonucleotides. 2008 Sep;18(3):245-56. doi: 10.1089/oli.2008.0126.

8.

Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.

García-Martínez LF, Mavankal G, Peters P, Wu-Baer F, Gaynor RB.

J Mol Biol. 1995 Dec 1;254(3):350-63.

PMID:
7490754
9.

Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element.

Ganguly S, Chaubey B, Tripathi S, Upadhyay A, Neti PV, Howell RW, Pandey VN.

Oligonucleotides. 2008 Sep;18(3):277-86. doi: 10.1089/oli.2008.0140.

10.

The interactions and recognition of cyclic peptide mimetics of Tat with HIV-1 TAR RNA: a molecular dynamics simulation study.

Li CH, Zuo ZC, Su JG, Xu XJ, Wang CX.

J Biomol Struct Dyn. 2013 Mar;31(3):276-87. doi: 10.1080/07391102.2012.698248. Epub 2012 Sep 3.

PMID:
22943434
11.

Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.

Arzumanov A, Walsh AP, Rajwanshi VK, Kumar R, Wengel J, Gait MJ.

Biochemistry. 2001 Dec 4;40(48):14645-54.

PMID:
11724578
13.

Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.

Garcia JA, Harrich D, Soultanakis E, Wu F, Mitsuyasu R, Gaynor RB.

EMBO J. 1989 Mar;8(3):765-78.

14.

Inhibition of HIV-1 in CEM cells by a potent TAR decoy.

Lee SW, Gallardo HF, Gaspar O, Smith C, Gilboa E.

Gene Ther. 1995 Aug;2(6):377-84.

PMID:
7584112
16.

Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication.

Hwang S, Tamilarasu N, Kibler K, Cao H, Ali A, Ping YH, Jeang KT, Rana TM.

J Biol Chem. 2003 Oct 3;278(40):39092-103. Epub 2003 Jul 11.

18.

Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.

Niikura M, Dornadula G, Zhang H, Mukhtar M, Lingxun D, Khalili K, Bagasra O, Pomerantz RJ.

Oncogene. 1996 Jul 18;13(2):313-22.

PMID:
8710370
19.

Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells.

Yamamoto R, Koseki S, Ohkawa J, Murakami K, Nishikawa S, Taira K, Kumar PK.

Nucleic Acids Res. 1997 Sep 1;25(17):3445-50.

Supplemental Content

Support Center